<?xml version='1.0' encoding='utf-8'?>
<document id="31849452"><sentence text="Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats."><entity charOffset="26-36" id="DDI-PubMed.31849452.s1.e0" text="Amiodarone" /><entity charOffset="41-50" id="DDI-PubMed.31849452.s1.e1" text="Quinidine" /><pair ddi="false" e1="DDI-PubMed.31849452.s1.e0" e2="DDI-PubMed.31849452.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s1.e0" e2="DDI-PubMed.31849452.s1.e1" /></sentence><sentence text="Eliglustat, a new oral substrate-reduction therapy, was recently approved as a first-line therapy for Gaucher's disease type 1 (GD1) patients" /><sentence text="" /><sentence text="The purpose of the present study was to develop and validate a simple UPLC-MS/MS method for the measurement of plasma-eliglustat concentration and to investigate the effects of amiodarone and quinidine on eliglustat metabolism in rats"><entity charOffset="177-187" id="DDI-PubMed.31849452.s4.e0" text="amiodarone" /><entity charOffset="192-201" id="DDI-PubMed.31849452.s4.e1" text="quinidine" /><entity charOffset="205-215" id="DDI-PubMed.31849452.s4.e2" text="eliglustat" /><pair ddi="false" e1="DDI-PubMed.31849452.s4.e0" e2="DDI-PubMed.31849452.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s4.e0" e2="DDI-PubMed.31849452.s4.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s4.e0" e2="DDI-PubMed.31849452.s4.e2" /><pair ddi="false" e1="DDI-PubMed.31849452.s4.e1" e2="DDI-PubMed.31849452.s4.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s4.e1" e2="DDI-PubMed.31849452.s4.e2" /></sentence><sentence text="" /><sentence text="Eighteen rats were randomly divided into three groups (n=6): control (0" /><sentence text="5% CMC-Na, group A), amiodarone (60 mg/kg, group B), and quinidine (100 mg/kg, group C)"><entity charOffset="3-9" id="DDI-PubMed.31849452.s7.e0" text="CMC-Na" /><entity charOffset="21-31" id="DDI-PubMed.31849452.s7.e1" text="amiodarone" /><entity charOffset="57-66" id="DDI-PubMed.31849452.s7.e2" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.31849452.s7.e0" e2="DDI-PubMed.31849452.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s7.e0" e2="DDI-PubMed.31849452.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s7.e0" e2="DDI-PubMed.31849452.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31849452.s7.e1" e2="DDI-PubMed.31849452.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s7.e1" e2="DDI-PubMed.31849452.s7.e2" /></sentence><sentence text=" Thirty minutes later, 10 mg/kg eliglustat was orally administered to each rat and concentrations of eliglustat in the rats determined by our UPLC-MS/MS method" /><sentence text="" /><sentence text="Amiodarone and quinidine increased the main pharmacokinetic parameters (AUC0→ &#10;                        t&#10;                     , AUC0→∞, and Cmax) of eliglustat significantly and decreased clearance obviously"><entity charOffset="0-10" id="DDI-PubMed.31849452.s10.e0" text="Amiodarone" /><entity charOffset="15-24" id="DDI-PubMed.31849452.s10.e1" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.31849452.s10.e0" e2="DDI-PubMed.31849452.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s10.e0" e2="DDI-PubMed.31849452.s10.e1" /></sentence><sentence text="" /><sentence text="Amiodarone and quinidine can elevate eliglustat exposure and have an inhibitory effect on eliglustat metabolism"><entity charOffset="0-10" id="DDI-PubMed.31849452.s12.e0" text="Amiodarone" /><entity charOffset="15-24" id="DDI-PubMed.31849452.s12.e1" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.31849452.s12.e0" e2="DDI-PubMed.31849452.s12.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s12.e0" e2="DDI-PubMed.31849452.s12.e1" /></sentence><sentence text=" Clearly, appropriate pharmacological studies of eliglustat in patients treated with amiodarone or quinidine should be done in future"><entity charOffset="49-59" id="DDI-PubMed.31849452.s13.e0" text="eliglustat" /><entity charOffset="85-95" id="DDI-PubMed.31849452.s13.e1" text="amiodarone" /><entity charOffset="99-108" id="DDI-PubMed.31849452.s13.e2" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.31849452.s13.e0" e2="DDI-PubMed.31849452.s13.e0" /><pair ddi="false" e1="DDI-PubMed.31849452.s13.e0" e2="DDI-PubMed.31849452.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s13.e0" e2="DDI-PubMed.31849452.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31849452.s13.e1" e2="DDI-PubMed.31849452.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31849452.s13.e1" e2="DDI-PubMed.31849452.s13.e2" /></sentence><sentence text="" /></document>